Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00377702
Status:
COMPLETED
Last Update Posted:
2016-02-18
First Post:
2006-09-14
Brief Title:
Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Heart Lung and Blood Institute NHLBI
Study Overview
Official Title:
Epidemiologic Study of Ethnicity and Lifetime Risks for Cardiovascular Disease
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cardiovascular disease CVD is one of the leading causes of death in the United States Currently there is little information about the lifetime risk of CVD among non-white ethnic groups This study will analyze data from participants in several ongoing clinical studies to identify the lifetime risk for CVD among various ethnicities
Detailed Description:
CVD affects millions of people in the United States Current treatment guidelines for CVD take into account an individuals risk of developing the disease within 10 years the intensity of therapy is usually matched to the 10-year risk magnitude However many individuals have a low 10-year risk of CVD but have an elevated lifetime risk of developing the disease Unfortunately few studies have examined the lifetime risks for CVD and these studies have been almost exclusively performed in the Caucasian population There have been no studies that focus on the lifetime risks for CVD among other ethnic groups Because the incidence of CVD and other causes of death vary among different ethnic groups it is important to examine each group separately Using data from ongoing clinical studies this study will evaluate the lifetime risks for CVD among different ethnic groups The results from this study will assist in estimating the future incidence of CVD among ethnic groups improving risk communication within patient care and identifying new populations of individuals at risk for CVD
This study will use previously collected data on 500000 individuals participating in pre-specified clinical studies Some of the participating studies include the following Atherosclerosis Risk in Communities Framingham Heart Honolulu Heart Puerto Rico Heart Health Coronary Artery Risk Development in Young Adults CARDIA Cardiovascular Health Chicago Heart Association Detection Project in Industry Womens Health Initiative Observational Studies and Multiple Risk Factor Intervention Trial MRFIT There will be no study visits specifically for this study Researchers will collect information on CVD risk factors and demographics including sex race and age they will then compare this information to overall survival CVD associated survival and lifetime risk for CVD
This study will use previously collected data on 500000 individuals participating in pre-specified clinical studies Some of the participating studies include the following Atherosclerosis Risk in Communities Framingham Heart Honolulu Heart Puerto Rico Heart Health Coronary Artery Risk Development in Young Adults CARDIA Cardiovascular Health Chicago Heart Association Detection Project in Industry Womens Health Initiative Observational Studies and Multiple Risk Factor Intervention Trial MRFIT There will be no study visits specifically for this study Researchers will collect information on CVD risk factors and demographics including sex race and age they will then compare this information to overall survival CVD associated survival and lifetime risk for CVD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R21HL085375 | NIH | None | httpsreporternihgovquickSearchR21HL085375 |